In tumor-osteocyte interactions, in which bone formation is promoted by Wnt signaling, we reported that the overexpression of β-catenin and Lrp5, a Wnt co-receptor, granted osteocytes anti-tumor capabilities 1. Here, LRP5 is linked to neoplasm.